Please use accurate information when answering these questions scientifically
Clinical trials have shown impressive results, with many participants losing 15-20% of their body weight, improving metabolic health, and reducing the risk of chronic diseases
Pfizer abandons weight-loss drug after liver injury The decision is another setback in the companys efforts to enter in the competitive market for GLP-1-based weight loss drugs Pfizer on Monday said it will discontinue the development of its experimental oral obesity drug danuglipron after a participant in a clinical trial reported a liver injury linked to the treatment
Hepatology, 2006, 43(1): 173-181
For older adults or those new to exercise, working with a physical therapist or trainer can help create a safe, effective plan
Whole-food supplementssuch as those from Standard Processoffer a thoughtful way to bridge nutrient gaps, support digestion and metabolism, and potentially allow a slower, more integrated path to your health goals